SAN FRANCISCO, February 15, 2017 /PRNewswire/ --
The global legionella testing market isexpected to reach USD 352.6 million by 2025, according to a new study by Grand View Research Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
According to CDC, the number of people suffering from Legionnaires' disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due the contaminated environment. The rising incidence of Legionellosis will drive the market growth in the coming years, especially in the industrial sector.
The conventional bacterial testing is least preferred nowadays, since it is labor intensive and time consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.
Browse full research report with TOC on "Legionella Testing Market Size & Forecast By Application (Water Testing [Microbial Culture, DFA Stain, PCR, Others], IVD Testing [Blood Culture, Urine Antigen Test, DFA Stain, PCR, Others]), And Trend Analysis From 2013 To 2025" at: http://www.grandviewresearch.com/industry-analysis/legionella-testing-market
Further Key Findings From the Study Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the legionella testing market on the basis of application, type, and region:
Read Our Blogs - Legionella Testing Market Outlook: Analyst Perspective
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...
Sclerotherapy is a procedure used to treat spider veins, varicose veins and hemorrhoids by directly ...
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...View All